Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients

Eur J Neurol. 2021 Jan;28(1):e9. doi: 10.1111/ene.14543. Epub 2020 Oct 12.

P E Doneddu¹, P De Sanctis², L Viganò³, C Selmi⁴, F Gentile¹, E Nobile-Orazio^{1

5}

¹ Department of Neurology, Neuromuscular and Neuroimmunology Service, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
² Department of Neurosurgery, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
³ Department of General Surgery, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
⁴ Department of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Institute - IRCCS, Rozzano, Italy.
⁵ Department of Medical Biotechnology and Translational Medicine, Milan University, Milan, Italy.

No abstract available

Keywords: Covid; Guillain-Barre syndrome; cranial nerves; cranial neuropathy; neurological disorders; peripheral neuropathies.

Publication types